Detection method for pharmaceutical service effect based on AIDS patient

A detection method, AIDS technology, applied in genomics, patient-specific data, informatics, etc., can solve problems such as social instability, insufficient response, and impact on social order and stability

Pending Publication Date: 2022-07-05
JIANGSU UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Treatments such as ART can reduce patient mortality, improve quality of life, and prevent HIV infection, but treatment alone cannot end the epidemic. The HIV pandemic will not only increase the human and financial costs of the health system, but may also cause social instability , affecting social order and stability
The current largest generation of young people is entering adolescence and adulthood, and existing tools and strategies are insufficient to deal with it, and the HIV pandemic will remain a major global challenge for the foreseeable future

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection method for pharmaceutical service effect based on AIDS patient
  • Detection method for pharmaceutical service effect based on AIDS patient

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] Below in conjunction with accompanying drawing and embodiment, the present invention is further described:

[0025] refer to figure 1 , a detection method based on the effect of pharmaceutical services for AIDS patients, including the following steps:

[0026] Step 1. Confirm the sample size and group them; call outpatients who have not received antiretroviral treatment and who have completed the sample exclusion of newly-treated HIV patients, and count them in order according to the chronological order of being selected. for the observation group and the control group.

[0027] Among them, the sample exclusion criteria in step 1 include: pregnant or breastfeeding women, severe complications, patients with mental illness and cognitive impairment, patients who are participating in other studies, and those who gave up, lost to follow-up, or transferred during the treatment process. patients diagnosed and died.

[0028] The formula for estimating the sample size is: w...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a detection method based on a pharmaceutical service effect of an AIDS patient, which comprises the following steps of: performing experimental detection on a virus load level of an HIV infected person, counting CD4 + T lymphocytes of peripheral blood of the AIDS patient, and analyzing a gene detection result of an HIV drug-resistant site; and comparing the virus load levels of the two groups of patients who receive the pharmaceutical service and do not receive the pharmaceutical service, the change of CD4 + T lymphocyte count and the generation of drug-resistant site results. According to the invention, on the basis of experimental data, it is expected to be proved that clinical pharmaceutical service treatment has been subjected to related investigation and research on medication compliance correlation of AIDS patients, and evidence support is expected to be provided for developing AIDS clinical pharmaceutical service in a larger range; and a special and standardized pharmaceutical service mode flow is established for AIDS patients for exploration.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical services for AIDS patients, in particular to a method for detecting the effect of pharmaceutical services for AIDS patients. Background technique [0002] AIDS is acquired immunodeficiency syndrome (AIDS), a chronic infectious disease caused by human immunodeficiency virus (HIV). Treatment such as ART can reduce patient mortality, improve quality of life and prevent HIV infection, but treatment alone cannot end the epidemic. The HIV pandemic will not only increase the human and financial costs of the health system, but may also cause social instability. , affecting social order and stability. The current largest generation of young people is entering adolescence and adulthood, and existing tools and strategies are insufficient to address it, and the HIV pandemic remains a major global challenge for the foreseeable future. [0003] In developed countries, such as in the United States, phar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G16H70/00G16H20/70G16H10/20G16H10/60G16B20/30G16B20/50
CPCG16H70/00G16H20/70G16H10/20G16H10/60G16B20/30G16B20/50
Inventor 虞晓云戚雪勇戈延茹
Owner JIANGSU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products